RaQualia Pharma Inc. (TYO:4579)

RaQualia Pharma Revenue

In the year 2025, RaQualia Pharma had annual revenue of 3.98B JPY with 28.10% growth. RaQualia Pharma had revenue of 1.67B in the quarter ending December 31, 2025, with 126.28% growth.

• Revenue: 3.98B
• Revenue Growth: +28.10%
• P/S Ratio: 5.88
• Revenue / Employee: 62.19M
• Employees: 64
• Market Cap: 23.39B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.98B	872.96M	28.10%
Dec 31, 2024	3.11B	1.21B	63.44%
Dec 31, 2023	1.90B	-1.02B	-34.85%
Dec 31, 2022	2.92B	142.00M	5.12%
Dec 31, 2021	2.78B	1.67B	150.77%